The group responsible for the examination and coordination of questions relating to the marketing authorisation of human medicines in two or more Member States in accordance with the mutual recognition or decentralised procedure. Abbreviated as CMDh.
More information can be found under 'Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh)'.